Improved Proteinuria Reduction with the use of Sparsentan and Targeted Release Budesonide in advanced IgAN

https://storage.unitedwebnetwork.com/files/1099/96c8a46e00fa19af3c2ef23a07062ed1.pdf
Improved Proteinuria Reduction with the use of Sparsentan and Targeted Release Budesonide in advanced IgAN
Neeharik
Mareedu
Praveen Errabelli errabelli.praveen@mayo.edu Mayo Clinic Health System Nephrology Eau Claire